• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CUV 0.39% $15.15

CLINUVEL PHARMACEUTICALS LIMITED - News & Media

Clinuvel Pharmaceuticals Limited is a global specialty pharmaceutical company. The... Clinuvel Pharmaceuticals Limited is a global specialty pharmaceutical company. The Company is focused on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations. The Company is engaged in managing and expanding commercial distribution of its lead drug candidate, SCENESSE, in Europe, the United States, Israel, and Australia for the treatment of a rare, genetic metabolic disorder, erythropoietic protoporphyria (EPP). The Company’s pipeline includes PRENUMBRA, NEURACTHEL, CUV9900, and Parvysmelanotide (VLRX001). PRENUMBRA is a liquid (non-solid) injectable formulation of afamelanotide designed to provide a flexible dose of afamelanotide, a synthetic analogue of natural a-melanocyte stimulating hormone. NEURACTHEL is a novel formulation of the melanocortin adrenocorticotropic hormone (ACTH), for neurological, endocrinological and degenerative disorders.More

No News & Media currently available.

(20min delay)
Last
$15.15
Change
-0.060(0.39%)
Mkt cap ! $758.0M
Open High Low Value Volume
$15.20 $15.21 $14.90 $562.9K 37.24K

Buyers (Bids)

No. Vol. Price($)
2 279 $15.91
 

Sellers (Offers)

Price($) Vol. No.
$14.39 9 1
View Market Depth
Last trade - 15.59pm 13/05/2024 (20 minute delay) ?
Last
$15.14
  Change
-0.060 ( 0.16 %)
Open High Low Volume
$15.11 $15.21 $14.95 4220
Last updated 15.59pm 13/05/2024 ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.